Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Heat Biologics, Inc. announced a planned development partnership of its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused ...
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Tuesday, December 21, 2021
Heat Biologics, Inc. a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, has executed a definitive merger agreement to acquire Elusys Therapeutics, a commercial-stage biodefense ...
read more
Heat Biologics, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announced the launch of its wholly-owned subsidiary, Skunkworx Bio, Inc. (“Skunkworx”), focused on the ...
read more
Heat Biologics Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it will be hosting a groundbreaking ceremony for the launch of its new planned San Antonio ...
read more
Wednesday, October 26, 2016
Heat Biologics a developer of gp96-based immunotherapies that activate a patient’s immune system to fight cancer, announced that it has entered into an agreement with the University of Miami for the license and development of a portfolio of patents ...
read more
HealthVerity announced that it has been awarded a contract with the Centers for Disease Control and Prevention (CDC) to provide a large-scale, fully interoperable, real-world dataset to advance a wide range of COVID-19 research, decision making, and ...
read more
HealthVerity has signed a multi-year Research Collaboration Agreement with the FDA to evaluate a range of different real-world datasets for their potential to inform the FDA's response to COVID-19.
read more
Friday, November 01, 2019
HealthTrust has awarded a 36-month group purchasing agreement effective November 1, 2019 for EcoVue ultrasound gel to York, Pennsylvania based HR Pharmaceuticals.
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more
Healthcare Triangle announced its formation as a new privately held U.S.-based company combining life sciences, healthcare delivery and business methodologies to accelerate cloud transformation, data lifecycle management and operational improvement ...
read more
Wednesday, August 22, 2018
Representatives from leading healthcare industry companies and associations, came together to explore the use of blockchain technology to support Drug Supply Chain Security Act (DSCSA) compliance.
read more
Monday, December 14, 2020
Health Decisions and OncoBay Clinical announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.
read more
Friday, February 16, 2018
B·R·A·H·M·S GmbH announced its sFlt-1, PlGF plus, PAPP-A and Free ßhCG KRYPTOR assays have received Class III Medical Device System License from Health Canada as an aid in screening for the risk of fetal trisomy 21, 18 and 13.
read more